Monika Yanovska Email & Phone Number
Who is Monika Yanovska? Overview
A concise factual answer block for searchers comparing this professional profile.
Monika Yanovska is listed as Associate Researcher at KU Leuven, a with 14748 employees, based in Germany. AeroLeads shows a matched LinkedIn profile for Monika Yanovska.
Monika Yanovska previously worked as Staff Scientist at 3R-Center Tübingen and Staff Scientist at 3R-Center Tübingen. Monika Yanovska holds Master'S Degree, Biomedical Sciences, General from Leiden University.
Email format at KU Leuven
This section adds company-level context without repeating Monika Yanovska's masked contact details.
Review company-level records connected to Monika Yanovska before choosing the right outreach path.
About Monika Yanovska
I am an enthusiastic entry level biomedical scientist with an experience in a few research areas, who is interested in further developing herself in the applications of microfluidics in stem cell biology. Gene and cell therapies to treat various disease are also of high interest.
Monika Yanovska's current company
Company context helps verify the profile and gives searchers a useful next step.
Monika Yanovska work experience
A career timeline built from the work history available for this profile.
Staff Scientist
Staff Scientist
Research Engineer
Division of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, SwedenAIMES Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, Sweden
Research Intern
AIMES Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, SwedenDivision of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, SwedenMSc Thesis Project: Patient-specific hiPSC-derived Microphysiological System of the Blood Brain Barrier to Study Impaired Brain Glucose Metabolism.• Cultivated human induced pluropitent stem cells (hiPSCs) derived from glucose transporter type 1 deficiency syndrome patients (and apparently healthy controls).• Differentiated and sorted them using magnetic- activated cells sorting (MACS) method into endothelial cells and pericytes.• Assessed morphology and functionality of the differentiated cells by measuring expression of cell type specific markers, incl. junction proteins (immunocytochemistry, ICC), barrier integrity (transednohelial electrical resistance (TEER) and molecular tracing), vascular tube formation, as well as quantitative polymerase chain reaction (qPCR).• Investigated the differentiated cells energy metabolism by measuring nutrient consumption and metabolite secretion.• Fabricated organ-on-a-chip (OoC) microfluidic platforms.• Developed seeding strategies for on-chip co-cultures of endothelial cells and pericytes.
Housekeeping And Maintenance Management
Part-time (minimum of 40 hours per month)
Research Intern
Division of Thrombosis and Haemostasis, Department of Internal MedicineProject: Cancer-associated thrombosis-on-a-chip: insights into colorectal cancer.• Isolated and cultivated human umbilical vein endothelial cells.• Cultured both colorectal cancer (CRC) cells and fibroblast cells to generate hanging-drop cell aggregates and collect supernatants.• Implemented the cultured endothelial cells and malignant cellular aggregates on a microfluidic platform that allowed the co-culturing of tumour spheroid-like formations with a perfused microvasculature.• Performed and optimized a real-time 3D barrier integrity assay on the microfluidic device.• Utilized ImageJ to analyze the obtained fluorescence images to study the influence of the malignant cells on the permeability of the vessels.• Carried out the high-sensitive 2D Electric Cell-substrate Impedance Sensing (ECIS) experiment to validate the obtained results from the 3D permeability experiments.• Conducted and optimized a real-time 3D thrombin generation experiment that was previously established by the lab on the microfluidic platform.• Analyzed the obtained images using ImageJ and manually converted the obtained fluorescence signal into its representing thrombin concentration to investigate the influence of the tumour cells on the production of thrombin.• Researched and wrote a report showcasing the potential implementation of this innovative technology to study cancer-associated thrombosis, especially focusing on the evaluation of the effects of five genes of interest on the development of thrombosis in a CRC setting.
Research Intern
Department of Psychiatry and Neuropsychology,School for Mental Health and Neuroscience (MHeNS)Project: The Effect of Sphingosine 1-phosphate Analogue FTY720 on Amyloid β Pathology and Neuroinflammation Associated with the Activation of Microglia and Astrocytes in a mouse model of Alzheimer’s Disease.• Conducted polymer chain reaction (PCR)- based genotyping to determine the animals possessing the presenilin 1 and amyloid precursor protein genes associated with AD.• Performed protein extraction through physical disruption using the method of sonication as a preparation for western blotting.• Carried out enzyme-linked immunosorbent assay (ELISA) to detect and quantify amyloid β protein concentration.• Neuronal tissue was dissected using a cryostat machine.• Performed IHC staining assessing antibodies for microglia and astrocytes markers concomitantly with amyloid plaques staining using Thioflavin S• Utilized ImajeJ to edit and analyze the images obtained from the staining to investigate the influence of FTY720 on both inflammation and amyloid plaques formation.
Research Intern
Department of Psychiatry and Neuropsychology,School for Mental Health and Neuroscience (MHeNS)BSc Thesis Project: Optimization of Immunohistochemistry Staining of Adeno-associated Virus-mediated Ceramide Transporter Protein (long isoform) Expression in Neurons in Wild Type Mouse Brain.• Set up the experiment with the help of thesis supervisor.• Cryostat sectioned previously obtained mouse neuronal tissue.• Performed immunohistochemistry (IHC) staining assessing the adeno-associated virus (AVV)- mediated expression of CERTL concomitantly with neuronal marker NeuN to investigate whether the rabbit polyclonal anti-CERTL stains predominantly neurons.• Utilized ImageJ to edit obtained images.• Researched and wrote a 13- page paper evaluating the efficiency of AAV- mediated CERTL expression over 12 weeks in wild type mouse brain and provided an optimized IHC staining protocol so that further research in transgenic mice expressing 5 familial Alzheimer’s disease (AD) mutations can be performed.
Monika Yanovska education
Master'S Degree, Biomedical Sciences, General
Bachelor'S Degree, Biomedical Sciences, General
Frequently asked questions about Monika Yanovska
Quick answers generated from the profile data available on this page.
What company does Monika Yanovska work for?
Monika Yanovska works for KU Leuven.
What is Monika Yanovska's role at KU Leuven?
Monika Yanovska is listed as Associate Researcher at KU Leuven.
Where is Monika Yanovska based?
Monika Yanovska is based in Germany while working with KU Leuven.
What companies has Monika Yanovska worked for?
Monika Yanovska has worked for Ku Leuven, 3R-Center Tübingen, Kth Royal Institute Of Technology, Scilifelab, and Hotel Steeds Aan Zee.
How can I contact Monika Yanovska?
You can use AeroLeads to view verified contact signals for Monika Yanovska at KU Leuven, including work email, phone, and LinkedIn data when available.
What schools did Monika Yanovska attend?
Monika Yanovska holds Master'S Degree, Biomedical Sciences, General from Leiden University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial